icon-folder.gif   Conference Reports for NATAP  
 
  IDSA/IDWeek
2015, October 7-11
San Diego
Back grey_arrow_rt.gif
 
 
 
HCV at IDSA, Treatment Study Results in HIV/HCV Coinfected, Cascade & Barriers to Care
 
 
  IDSA: Ledipasvir/Sofosbuvir Is Safe and Effective for the Treatment of Patients with Genotype 1 Chronic HCV Infection in Both HCV Mono- and HIV/HCV Coinfected Patients (10/15/15)
 
IDSA: Lack of Drug Interactions Between Boosted and Unboosted TAF-Based Antiretroviral Single-Tablet Regimens (E/C/F/TAF, R/F/TAF) and the anti-HCV Single-Tablet Regimen Ledipasvir/Sofosbuvir (10/13/15)
 
IDSA: 12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens (10/15/15)
 
IDSA: 12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by Black Race (10/15/15)
 
IDSA: C-EDGE: INTEGRATED ANALYSIS FROM THE PHASE 2/3 STUDIES OF ELBASVIR / GRAZOPREVIR IN PATIENTS WITH HCV/HIV (2) (10/19/15)
 
---------------------
 
IDSA: HCV Cascade/Barriers in Philadelphia - "Meet the Professor: Overcoming barriers to HCV care" (10/21/15)
 
IDSA: Hepatitis C Virus (HCV) In Young Suburban Heroin Users In New Jersey; Part Of The Second Wave Of Hepatitis C (10/19/15)
 
IDSA: Linkage to Care for Hepatitis C: Creating a Cascade of Care to Identify Gaps at the Individual Hospital Level (Bellevue Hospital-NYC) (10/19/15)
 
IDSA: Diagnosed, staged and untreated: Hepatitis C fibrosis severity by transient elastography (TE) in an inner city clinic (10/19/15)
 
IDSA: HCV Cascade/Denver - Impact of Interferon-Era HCV Treatment Restrictions on Current Referral and Treatment Trends (10/19/15)
 
IDSA: Gender, Ethnicity, IDU, and Risk for HCV Among New York City Jail Inmates (10/19/15)
 
IDSA: Exploring the Benefits of an Enhanced Social Work Intervention within the HCV Cascade of Care (10/19/15)
 
Risk of Deferring HCV Treatment - CDC CheCS: "All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C Virus"- (10/20/15)